©2024 Stanford Medicine
Lymphedema Study for Arm or Leg Lymphedema
Not Recruiting
Trial ID: NCT02257970
Purpose
This study compares the effectiveness of a study drug versus placebo in the treatment of
lymphedema.
Official Title
Placebo-controlled, Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.
Stanford Investigator(s)
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Eligibility
Inclusion Criteria:
- a history of lymphedema of one or more limbs (unilateral or bilateral), with a
duration of > 6 months.
Exclusion Criteria:
- Patients with active cancer, infection or bleeding tendency will be excluded.
- We will also exclude patients with medical contraindications to NSAIDs, including
history of allergies, know gastrointestinal intolerance, or other serious systemic
illness (e.g., renal failure, hepatic dysfunction, congestive heart failure,
neurological or psychological impairment) that would impair the patients' ability to
participate.
- Minors (<18 years of age) *>90 years of age
Intervention(s):
drug: Placebo
drug: Ketoprofen
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Leslie Roche, RN
650-723-1396